We report on a series of three patients with an unusual syndrome of eosinophilia and myalgia associated with the oral ingestion of tryptophan that was recognized in New Mexico in October 1989. All three patients, who were women 37 to 44 years of age, had severe muscle pain, muscle weakness, mouth ulcers, and striking eosinophilia (more than 8 X 10(9) cells per liter). Other manifestations included fever, abdominal pain, dyspnea, skin rash, and elevated serum concentrations of aminotransferase and aldolase. The women had been taking tryptophan in doses of 1.2 to 2.4 g a day for three weeks to 2 1/2 years. The discontinuation of tryptophan and the initiation of glucocorticoid treatment resulted in improvement, but all three women were still symptomatic three to five months later. Tests for trichinosis and other parasites and for allergic and connective-tissues disorders were negative, and serum immunoglobulin concentrations and erythrocyte sedimentation rates were normal. A muscle biopsy in one patient and biopsies of the vagina, liver, and other abdominal organs in another revealed eosinophilic infiltration, as well as the extracellular deposition of eosinophil-granule major basic protein. All three patients had elevated serum and urinary levels of this protein and eosinophil-derived neurotoxin, indicative of eosinophil degranulation. The syndrome of eosinophilia and myalgia in association with the ingestion of tryptophan that was seen in these three patients is a newly recognized adverse effect of tryptophan ingestion. Our identification of this association in these patients led to the discovery of an epidemic of what is now called the eosinophilia-myalgia syndrome.
Source Information
Los Alamos Medical Center, NM 87544.
This article has been cited by other articles:
Zhang, Z., Cherryholmes, G., Mao, A., Marek, C., Longmate, J., Kalos, M., Amand, R. P. ST., Shively, J. E.
(2008). High Plasma Levels of MCP-1 and Eotaxin Provide Evidence for an Immunological Basis of Fibromyalgia. Exp. Biol. Med.
233: 1171-1180
[Abstract][Full Text]
Deng, G., Cassileth, B. R.
(2005). Integrative Oncology: Complementary Therapies for Pain, Anxiety, and Mood Disturbance. CA Cancer J Clin
55: 109-116
[Abstract][Full Text]
Moschella, S. L., Kay, J., Mackool, B. T., Liu, V.
(2004). Case 35-2004 - A 68-Year-Old Man with End-Stage Renal Disease and Thickening of the Skin. NEJM
351: 2219-2227
[Full Text]
Nutman, T. B., Kradin, R. L.
(2002). Case 1-2002- A 24-Year-Old Woman with Paresthesias and Muscle Cramps after a Stay in Africa. NEJM
346: 115-122
[Full Text]
Moertel, C. L., Kazacos, K. R., Butterfield, J. H., Kita, H., Watterson, J., Gleich, G. J.
(2001). Eosinophil-Associated Inflammation and Elaboration of Eosinophil-Derived Proteins in 2 Children With Raccoon Roundworm (Baylisascaris procyonis) Encephalitis. Pediatrics
108: e93-93
[Abstract][Full Text]
Hertzman, P. A., Clauw, D. J., Duffy, J., Medsger, T. A. Jr, Feinstein, A. R.
(2001). Rigorous New Approach to Constructing a Gold Standard for Validating New Diagnostic Criteria, as Exemplified by the Eosinophilia-Myalgia Syndrome. Arch Intern Med
161: 2301-2306
[Abstract][Full Text]
Stahl, J. L., Cook, E. B., Pariza, M. A., Cook, M. E., Graziano, F. M.
(2001). Effect of L-Tryptophan Supplementation on Eosinophils and Eotaxin in Guinea Pigs. Exp. Biol. Med.
226: 177-184
[Abstract][Full Text]
Fernstrom, J. D
(2000). Can nutrient supplements modify brain function?. Am. J. Clin. Nutr.
71: 1669S-1673
[Abstract][Full Text]
Fugh-Berman, A., Cott, J. M.
(1999). Dietary Supplements and Natural Products as Psychotherapeutic Agents. Psychosom. Med.
61: 712-728
[Abstract][Full Text]
Fishman, A. P.
(1999). Aminorex to Fen/Phen : An Epidemic Foretold. Circulation
99: 156-161
[Full Text]
Sullivan, E. A., Kamb, M. L., Jones, J. L., Meyer, P., Philen, R. M., Falk, H., Sinks, T.
(1996). The Natural History of Eosinophilia-Myalgia Syndrome in a Tryptophan-Exposed Cohort in South Carolina. Arch Intern Med
156: 973-979
[Abstract]
Varga, J., Jimenez, S. A.
(1994). Chemical Exposure-Induced Cutaneous Fibrosis: Lessons From 'Experiments of Nature'. Arch Dermatol
130: 97-100
[Abstract]
Hatch, D. L., Goldman, L. R.
(1993). Reduced Severity of Eosinophilia-Myalgia Syndrome Associated With the Consumption of Vitamin-Containing Supplements Before Illness. Arch Intern Med
153: 2368-2373
[Abstract]
Sternberg, E. M., Chrousos, G. P., Wilder, R. L., Gold, P. W.
(1992). The Stress Response and the Regulation of Inflammatory Disease. ANN INTERN MED
117: 854-866
[Abstract]
Hauser, S. L., Doolittle, T. H., Lopez-Bresnahan, M., Shahani, B., Schoenfeld, D., Shih, V. E., Growdon, J., Lehrich, J. R.
(1992). An Antispasticity Effect of Threonine in Multiple Sclerosis. Arch Neurol
49: 923-926
[Abstract]
Hedberg, K., Urbach, D., Slutsker, L., Matson, P., Fleming, D.
(1992). Eosinophilia-Myalgia Syndrome: Natural History in a Population-Based Cohort. Arch Intern Med
152: 1889-1892
[Abstract]
Philen, R. M., Ortiz, D. I., Auerbach, S. B., Falk, H.
(1992). Survey of Advertising for Nutritional Supplements in Health and Bodybuilding Magazines. JAMA
268: 1008-1011
[Abstract]
Hertzman, P. A., Maddoux, G. L., Sternberg, E. M., Heyes, M. P., Mefford, I. N., Kephart, G. M., Gleich, G. J.
(1992). Repeated Coronary Artery Spasm in a Young Woman With the Eosinophilia-Myalgia Syndrome. JAMA
267: 2932-2934
[Abstract]
Varga, J., Uitto, J., Jimenez, S. A.
(1992). The Cause and Pathogenesis of the Eosinophilia-Myalgia Syndrome. ANN INTERN MED
116: 140-147
[Abstract]
Kamb, M. L., Murphy, J. J., Jones, J. L., Caston, J. C., Nederlof, K., Horney, L. F., Swygert, L. A., Falk, H., Kilbourne, E. M.
(1992). Eosinophilia-Myalgia Syndrome in L-Tryptophan--Exposed Patients. JAMA
267: 77-82
[Abstract]
Sidransky, H., Verney, E., Cosgrove, J. W., Schwartz, A. M.
(1992). Effect of Benzodiazepines on Tryptophan Binding to Rat Hepatic Nuclei. Toxicol Pathol
20: 350-356
[Abstract]
Culpepper, R. C., Williams, R. G., Mease, P. J., Koepsell, T. D., Kobayashi, J. M.
(1991). Natural History of the Eosinophilia-Myalgia Syndrome. ANN INTERN MED
115: 437-442
[Abstract]
James, T. N., Kamb, M. L., Sandberg, G. A., Silver, R. M., Kilbourne, E. M.
(1991). Postmortem Studies of the Heart in Three Fatal Cases of the Eosinophilia-Myalgia Syndrome. ANN INTERN MED
115: 102-110
[Abstract]
Martinez-Osuna, P., Espinoza, L. R.
(1991). On the Treatment of the Eosinophilia-Myalgia Syndrome. Arch Intern Med
151: 1239-1239
[Abstract]
Philen, R. M., Eidson, M., Kilbourne, E. M., Sewell, C. M., Voorhees, R.
(1991). Eosinophilia-Myalgia Syndrome: A Clinical Case Series of 21 Patients. Arch Intern Med
151: 533-537
[Abstract]
(1990). Occupational and Environmental Medicine: The Internist's Role. ANN INTERN MED
113: 974-982
[Abstract]
Hertzman, P. A.
(1990). Informing Physicians About Promising New Treatments for Severe Disease. JAMA
264: 1947-1947
[Abstract]
Swygert, L. A., Maes, E. F., Sewell, L. E., Miller, L., Falk, H., Kilbourne, E. M.
(1990). Eosinophilia-Myalgia Syndrome: Results of National Surveillance. JAMA
264: 1698-1703
[Abstract]
LEWKONIA, R. M.
(1990). Myalgia and Eosinophilia Associated With Ingestion of Tryptophan: An Intriguing New Syndrome. Arch Intern Med
150: 2005-2007
[Abstract]
Slutsker, L., Hoesly, F. C., Miller, L., Williams, L. P., Watson, J. C., Fleming, D. W.
(1990). Eosinophilia-Myalgia Syndrome Associated With Exposure to Tryptophan From a Single Manufacturer. JAMA
264: 213-217
[Abstract]
(1990). TRYPTOPHAN AND EOSINOPHILIA-MYALGIA SYNDROME: CLINICAL UPDATE. JWatch General
1990: 2-2
[Full Text]
